Inventor
GIDDA JASWANT S
US16 patents
⚠️ This page may combine multiple inventors who share the name “GIDDA JASWANT S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LILLY CO ELI
15 patentsUS5434174AJul 18, 1995
Isoxazole derivatives for the treatment of irritable bowel syndrome
LILLY CO ELI57 citations96
US5688807ANov 18, 1997
Method for treating 5HT2B receptor related conditions
LILLY CO ELI24 citations92
US5340838AAug 23, 1994
Method of inhibiting gastric acid secretion with 2-phenylcyclopropylamines
LILLY CO ELI22 citations92
US5216002AJun 1, 1993
Method of treating inflammatory bowel disease
LILLY CO ELI29 citations92
US4920102AApr 24, 1990
Method for treating gastrointestinal disorders
LILLY CO ELI29 citations92
US5594034AJan 14, 1997
Method of inhibiting gastric acid secretion with 8-substituted-2-amino-1,2,3,4-tetrahydronapthalene
LILLY CO ELI13 citations82
US5096908AMar 17, 1992
Method of inhibiting gastric acid secretion
LILLY CO ELI18 citations82
US5594025AJan 14, 1997
Method of inhibiting gastric acid secretion with 5-substituted-3-aminochromane
LILLY CO ELI5 citations74
US5576352ANov 19, 1996
Method of inhibiting gastric acid secretion with aryloxypropanolamines
LILLY CO ELI6 citations74
US5457120AOct 10, 1995
Method of inhibiting gastric acid secretion with 4- amino-1, 3, 4, 5 tetrahydrobenzo [c,d]indoles
LILLY CO ELI5 citations74
US5258379ANov 2, 1993
Method of inhibiting gastric acid secretion with n-arylpiperazines
LILLY CO ELI16 citations74
US5158956AOct 27, 1992
Method of inhibiting gastric acid secretion with benzodioxanes
LILLY CO ELI15 citations74
US5736544AApr 7, 1998
Naphthylpiperazinyl compounds useful for treating 5HT2B receptor mediated conditions
LILLY CO ELI9 citations73
US5387690AFeb 7, 1995
Method of treating inflammatory bowel disease
LILLY CO ELI5 citations73
US5705519AJan 6, 1998
Method for treating 5-HT2B receptor related conditions
LILLY CO ELI11 citations70